BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.580
-0.030 (-1.86%)
At close: Dec 5, 2025, 4:00 PM EST
1.520
-0.060 (-3.80%)
After-hours: Dec 5, 2025, 4:40 PM EST
BioVie Market Cap
BioVie has a market cap or net worth of $11.91 million as of December 5, 2025. Its market cap has decreased by -80.35% in one year.
Market Cap
11.91M
Enterprise Value
-12.96M
1-Year Change
-80.35%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $11.91M, a decrease of -77.10%. That is a compound annual growth rate of -24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 12.10M | -65.92% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |